If you could vote on Brexit now which option would you choose?

AstraZeneca says early trial data indicates third dose helps against Omicron

AstraZeneca said that preliminary data from a trial showed that its COVID-19 shot, Vaxzevria, generated an increase in antibodies against the Omicron and other variants when given as a third booster dose. The increased response, also against the Delta variant, was seen in a blood analysis of people who were previously vaccinated with either Vaxzevria or an mRNA vaccine, the drugmaker said, adding that it would submit this data to regulators worldwide given the urgent need for boosters. read more

Reuters - January 13, 2022

View the full story here: https://www.reuters.com/business/healthcare-pharmaceuticals/astrazeneca-says-higher-antibody-response-against-omicron-with-booster-dose-2022-01-13/